Literature DB >> 29057556

Tumor-derived exosomes enhance invasion and metastasis of salivary adenoid cystic carcinoma cells.

Jin Hou1, Fangyuan Wang1, Xiaohao Liu1, Mengyang Song1, Xuemin Yin1.   

Abstract

OBJECTIVES: Tumor-derived exosomes (TDE) have been shown to participate in different steps of the dissemination of cancer cells. However, the role of salivary adenoid cystic carcinoma-derived (SACC-derived) exosomes had not been documented in SACC. The study aims to explore the functions of SACC-derived TDE in SACC progression and investigate potential mechanisms.
METHODS: Salivary adenoid cystic carcinoma cell line SACC-83 was used to generate TDE. Afterward, SACC-83 or HUVECs were cocultured with or without TDE. Tumor migration, tumor invasion, and endothelial permeability were examined by wound healing assay, tumor invasion assay, endothelial permeability assay, and tumor cell transendothelial migration assay, respectively. Moreover, the expression levels of cell junction-related proteins were examined by qRT-PCR and Western blot.
RESULTS: Salivary adenoid cystic carcinoma -83-derived exosomes were taken up by their host cells. Meanwhile, TDE increased migration and invasion capacity of SACC-83 cells and enhanced endothelial cell permeability. Furthermore, we demonstrated that the expression of cell junction-related proteins (Claudins and ZO-1) was downregulated, which is presumably involved in the TDE-mediated promotion of migration, invasion, and metastasis.
CONCLUSION: The results suggested that SACC cell-derived exosomes were loaded with individual components that could enhance invasiveness and induce microenvironment changes, thus promoting SACC aggression.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cell junction; invasion; metastasis; salivary adenoid cystic carcinoma; tumor-derived exosomes

Mesh:

Substances:

Year:  2017        PMID: 29057556     DOI: 10.1111/jop.12654

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  [Adenoid cystic carcinoma cells produce exosomes that promote tumor cell proliferation].

Authors:  Xiaohao Liu; Fangyuan Wang; Jin Hou; Leitao Zhang; Zhifeng Chen; Xuemin Yin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

Review 2.  The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers.

Authors:  Changqing Xie; Ning Ji; Zhangui Tang; Jing Li; Qianming Chen
Journal:  Mol Cancer       Date:  2019-04-06       Impact factor: 27.401

3.  Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI.

Authors:  Bingyue Duan; Si Shi; Huijun Yue; Bo You; Ying Shan; Ziyu Zhu; Lili Bao; Yiwen You
Journal:  J Cancer       Date:  2019-10-22       Impact factor: 4.207

Review 4.  Roles and clinical application of exosomal circRNAs in the diagnosis and treatment of malignant tumors.

Authors:  Dong Ye; Mengdan Gong; Yongqin Deng; Shuai Fang; Yujie Cao; Yizhen Xiang; Zhisen Shen
Journal:  J Transl Med       Date:  2022-04-05       Impact factor: 5.531

5.  Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.

Authors:  Chengdong Liu; Xiaohan Zhou; Qian Long; Hanyi Zeng; Qingcan Sun; Yuting Chen; Dehua Wu; Li Liu
Journal:  Oncogene       Date:  2020-10-27       Impact factor: 9.867

6.  Potential biological functions of microvesicles derived from adenoid cystic carcinoma.

Authors:  Zhuoyuan Zhang; Chaoran Yan; Bo Li; Longjiang Li
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

Review 7.  Emerging functions and clinical applications of exosomes in human oral diseases.

Authors:  Qiao Peng; Jing-Ya Yang; Gang Zhou
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

Review 8.  Extracellular Vesicles in Head and Neck Cancer: A Potential New Trend in Diagnosis, Prognosis, and Treatment.

Authors:  Xinyu Qu; Jing-Woei Li; Jason Chan; Katie Meehan
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.